ESR1 and breast cancer: For this purpose, we assessed six well-established immunohistochemical markers (ER, PR, HER2, Ki67, Bcl-2 and p53) in tumor samples of breast cancer cases from the prospective European Prospective Investigation into Cancer and Nutrition (EPIC)-Germany Study.